Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer’s disease, deposition of amyloid-β is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-β and increase the formation of amyloid-β oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-β pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-β pathology in transgenic double-mutant APPSwePSEN1dE9 mice. By contrast, homogenates from brains of APPSwePSEN1dE9 mice failed to induce seeding and spreading of amyloid-β pathology in ASC-deficient APPSwePSEN1dE9 mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-β pathology in APPSwePSEN1dE9 mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-β pathology in patients with Alzheimer’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta was shown to exacerbate tau pathologies [97] and reduce microglial phagocytic activity [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“Rat research has identified the NLRP3-ASC inflammasome as a major mechanism through which microglia may drive pathological features of AD [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“In turn, the NLRP3 inflammasome is essential for the development and progression of Aβ pathology in mice29 and may drive tau pathology through Aβ-induced microglial activation30.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [29]
In the citing paper
“Pyroptosis of glial cells leads to release of ASC specks into the extracellular space, where it binds rapidly to Aβ peptides, increasing the aggregation of Aβ.357”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [357]
In the citing paper
“In that study, ASC-bound Aβ was detected in brain samples from AD patients, but not in samples from age-matched controls without dementia.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [80]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Self-citationUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cited by
Items 501–600 of 1,002
Microglial Transforming Growth Factor-β Signaling in Alzheimer’s Disease
Vidovic, N., & Spittau, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063090 · Cited by 25
“These results suggest that there is a strong correlation of ASC specks and A β deposition in vivo [152].”
BackgroundResearch Progress on the Pathogenesis, Diagnosis, and Drug Therapy of Alzheimer’s Disease
Yang, Y., & Qiu, L. (2024) · Brain Sciences · doi:10.3390/brainsci14060590 · Cited by 23
Mechanisms of NLRP3 activation and pathology during neurodegeneration
Jose, S., Groves, N. J., Roper, K. E., & Gordon, R. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106273 · Cited by 23
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease
Seplovich, G., Bouchi, Y., Vaccari, J. P. D. R., Pareja, J. C. M., Reisner, A., Blackwell, L. S., Mechref, Y. S., Wang, K., Tyndall, J. A., Tharakan, B., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00107 · Cited by 22
The role of gut microbiota‐derived metabolites in neuroinflammation
Mu, L., & Wang, Y. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70001 · Cited by 23
“42 Clinical studies have shown that BA levels are closely associated with cognitive dysfunction in patients with AD.”
cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeutic opportunities
Fazal, F., Dar, N. J., Ahamad, S., Khan, S., Bano, N., Saha, S., Nazir, A., & Bhat, S. A. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101444 · Cited by 24
Influence of manganese exposure on cognitive function, plasma APP and Aβ levels in older men
Zhang, J., Yang, Y., Yang, X., Qin, J., Wei, X., Peng, Y., Li, Z., Zhang, L., Zhang, Z., & Zou, Y. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126788 · Cited by 23
Nizami, S., Millar, V., Arunasalam, K., Zarganes‐Tzitzikas, T., Brough, D., Tresadern, G., Brennan, P. E., Davis, J. B., Ebner, D. V., & Daniel, E. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-94850-w · Cited by 21
Johnson, N. H., Kerr, N. A., Vaccari, J. P. D. R., Bramlett, H. M., Keane, R. W., & Dietrich, W. D. (2023) · Translational research · doi:10.1016/j.trsl.2023.02.001 · Cited by 23
Ribeiro, M. D. C., Iracheta‐Vellve, A., Babuta, M., Calenda, C. D., Copeland, C., Zhuang, Y., Lowe, P., Hawryluk, D., Catalano, D., Cho, Y., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000298 · Cited by 24
Self-citationMolecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease
Ou-Yang, P., Cai, Z., & Zhang, Z.-H. (2023) · Aging and Disease · doi:10.14336/ad.2023.0106 · Cited by 28
Lau, S., Fu, A. K. Y., & Ip, N. Y. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15933 · Cited by 24
Neuroinflammation: The Abused Concept
Galea, E., & Graeber, M. B. (2023) · ASN NEURO · doi:10.1177/17590914231197523 · Cited by 22
“It has been proposed that reduced “neuroinflammation” accounts for resilience (Viviano et al., 2022).”
BackgroundBeltran-Lobo, P., Hughes, M. M., Troakes, C., Croft, C. L., Rupawala, H., Jutzi, D., Ruepp, M., Jiménez-Sánchez, M., Perkinton, M. S., Kassiou, M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.011 · Cited by 24
“accompanying cognitive deficits in mice (Heneka et al., 2013; Ising et al., 2019; Stancu et al., 2019; Venegas et al., 2017).”
Opportunities and challenges for the development of covalent chemical immunomodulators
Backus, K. M., Cao, J. X., & Maddox, S. M. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.05.050 · Cited by 21
The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer’s Disease
Golzari-Sorkheh, M., Brown, C. E., Weaver, D. F., & Reed, M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210660 · Cited by 23
Alzheimer’s Disease, Sleep Disordered Breathing, and Microglia: Puzzling out a Common Link
Ulland, T. K., Ewald, A. C., Knutson, A. O., Marino, K. M., Smith, S. M. C., & Watters, J. J. (2021) · Cells · doi:10.3390/cells10112907 · Cited by 21
“Microglial function in AD is complex, having both detrimental [80,81] and neuroprotective activities [82–85].”
BackgroundInfluentialChen, S., Hu, N., Wang, H., & Li, G. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105104 · Cited by 21
Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
Ayyubova, G., & Fazal, N. (2024) · Brain Sciences · doi:10.3390/brainsci14050434 · Cited by 24
“Alterations of the microglial phenotype in AD lead to the activation of inflammasome signaling and the release of excessive inflammatory cytokines, which, in turn, promotes neurotoxicity and excessive microglial synapse elimination [12,44,45].”
BackgroundNLRP3 inflammasome activation and pyroptosis are dispensable for tau pathology
Paesmans, I., Kolen, K. V., Vandermeeren, M., Shih, P., Wuyts, D., Boone, F., Sanchez, S. G., Grauwen, K., Hauwermeiren, F. V., Opdenbosch, N. V., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1459134 · Cited by 20
“Nlrp3 inflammasome deficiency in transgenic APP/PS1 mice was shown to reduce A β plaque load and significantly alleviate memory loss and pathological behavior (Heneka et al., 2012; Venegas et al., 2017).”
BackgroundAdvances in Genetic and Molecular Understanding of Alzheimer’s Disease
Ibáñez, L., Cruchaga, C., & Fernández, M. V. (2021) · Genes · doi:10.3390/genes12081247 · Cited by 22
“Upon microglia activation by Aβ deposits, the NLRP3 inflammasome assembles and initiates an inflammatory response, which contributes to the seeding and spreading of Aβ in AD mouse models [21].”
BackgroundBi-Directional Relationship Between Autophagy and Inflammasomes in Neurodegenerative Disorders
Panda, C., & Mahapatra, R. K. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01184-2 · Cited by 23
TSPO Deficiency Exacerbates GSDMD-Mediated Macrophage Pyroptosis in Inflammatory Bowel Disease
Zhang, X., Han, J., Xu, Y., Cai, M., Gao, F., Han, J., Wang, D., Fu, Y., Chen, H., He, W., et al. (2022) · Cells · doi:10.3390/cells11050856 · Cited by 22
“LPS at a final concentration of 1 μg/mL was added for pre-stimulation for 3 h before the boost stimulation with ATP at a final concentration of 5 mmol/L, as described previously [26].”
MethodThe Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
Busch, L., Eggert, S., Endres, K., & Bufe, B. (2022) · Cells · doi:10.3390/cells11213421 · Cited by 23
Potential of Capric Acid in Neurological Disorders: An Overview
Shekhar, N., Tyagi, S., Rani, S., & Thakur, A. K. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03809-4 · Cited by 24
NLRP3 ‐directed antisense oligonucleotides reduce microglial immunoactivities in vitro
Braatz, C., Komes, M. P., Ravichandran, K. A., de Fragas, M. G., Griep, A., Schwartz, S., McManus, R. M., & Heneka, M. T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15778 · Cited by 21
“…a danger-associated molecular pattern (DAMP), triggering neuroinflammation through the activation of pattern recognition receptors (PRRs) on microglia (Venegas et al., 2017; Weiner & Frenkel, 2006), which are heterogenous and may react in different ways to this challenge (Paolicelli et al., 2022).”
Self-citationSystems biology and gene networks in Alzheimer’s disease
Wang, Z.-T., Tan, C., Tan, L., & Yu, J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.007 · Cited by 21
“Many distinctive processes of Alzheimer’s disease (AD) add the complexity of the disease (Heppner et al., 2015; Jaunmuktane et al., 2015; Raj et al., 2014; Rhinn et al., 2013; Venegas et al., 2017; WetzelSmith et al., 2014; Xu et al., 2017).”
BackgroundEnduring Neuroprotective Effect of Subacute Neural Stem Cell Transplantation After Penetrating TBI
Kassi, A., Mahavadi, A. K., Clavijo, A., Caliz, D., Lee, S. W., Ahmed, A. I., Yokobori, S., Hu, Z., Spurlock, M. S., Wasserman, J. M., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2018.01097 · Cited by 21
Aftabizadeh, M., Tatarek‐Nossol, M., Andreetto, E., Bounkari, O. E., Kipp, M., Beyer, C., Latz, E., Bernhagen, J., & Kapurniotu, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00260 · Cited by 22
Self-citationShi, J., Wang, B., Jiang, T., Gao, L., Zhang, Y., & Xu, J. L. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200359 · Cited by 20
Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
Grossmann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094805 · Cited by 20
“In particular, inflammatory processes, proceeding from activated microglia cells and their release of inflammasome-derived, proinflammatory ASC (apoptosis-associated speck-like protein containing a CARD) protein complexes and cytokine peptides promote the formation and spread of cerebral Aβ deposits [44].”
BackgroundThe Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
Xie, Z., Meng, J., Wu, Z., Nakanishi, H., Hayashi, Y., Kong, W., Lan, F., Narengaowa, Yang, Q., Qing, H., et al. (2023) · The Neuroscientist · doi:10.1177/10738584211070273 · Cited by 19
Alzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 21
“ASC, an apoptosis-associated speck-like protein with a caspase recruitment domain, is released by microglia and controls the spread of disease within and between brain regions [36].”
Zheng, R., Yan, Y., Pu, J., & Zhang, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169088 · Cited by 20
“Importantly, multiple studies have shown that proteins capable of self-aggregating into macromolecules can promote the accumulation of disease-causing proteins [69,70].”
BackgroundHe, Y., Chen, X., Wu, M., Hou, X., & Zhou, Z. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1073511 · Cited by 19
“Moreover, the progression of AD is characterized by the swift binding of CARD/ASC-containing bridging proteins released by microglia pyroptosis to Aβ, which leads to an increase in Aβ oligomer and aggregate formation (Venegas et al., 2017).”
BackgroundHidden Aspects of Valency in Immune System Regulation
Samir, P., & Kanneganti, T. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.10.005 · Cited by 20
Oh, E.-J., Kang, J.-H., Jo, K. W., Shin, W.-S., Jeong, Y.-H., Kang, B., Rho, T.-Y., Jeon, S. Y., Lee, J., Song, I., et al. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01275-y · Cited by 19
“have reported that neuroinflammation can accelerate Aβ aggregation and microglia toxicity in the pathological condition of Alzheimer’s disease since increased inflammasome components could act as seeds for Aβ aggregation [35, 38].”
BackgroundImmunotherapy for neurodegeneration?
Liu, Y., & Aguzzi, A. (2019) · Science · doi:10.1126/science.aaw0685 · Cited by 19
Microglia pack a toolbox for life
Zengeler, K. E., & Lukens, J. R. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.03.010 · Cited by 19
Shi, J., Song, C., Zhang, P., Wang, J., Huang, W., Yu, T., Wei, Z., Wang, L., Zhao, L., Zhang, R., et al. (2025) · Theranostics · doi:10.7150/thno.104709 · Cited by 18
“Multiple studies have reported that microglia-mediated neuroinflammation promotes the production and seeding of Aβ plaques [59, 60].”
Ramos, J. M. P., Castellani, G., Kviatcovsky, D., Croese, T., Tsitsou-Kampeli, A., Burgaletto, C., Abellanas, M. A., Cahalon, L., Colaiuta, S. P., Salame, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58494-y · Cited by 20
“We observed no effect on both A β plaques and soluble A β 42 (Supplementary Fig.”
Joshi, P., Riffel, F., Kumar, S., Villacampa, N., Theil, S., Parhizkar, S., Haass, C., Colonna, M., Heneka, M. T., Arzberger, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01263-x · Cited by 18
Self-citationAnwar, M. M. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01270-5 · Cited by 18
“…TREM-1 may potentiate brain damage and neurodegeneration by promoting microglia pyrop-tosis via initiating NLRP3/caspase-1 mechanisms along with activated oxidative stress and triggered inflammatory cytokines (Feng et al. 2019; Venegas et al. 2017; Zhang et al. 2022; de Oliveira Matos et al. 2020).”
BackgroundYin, D., Zhao, L. X., Deng, S., Xie, Y., Ro, K.-S., Yang, Z., Du, L., Xie, J., & Wei, D. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10208-w · Cited by 19
“Progressive cerebral deposition of Aβ in brain regions serving memory and cognition is an invariant and defining feature of AD [40].”
Ren, L., Yang, H., Wang, H., Qin, S., Zhan, X., Li, H., Wei, Z., Fang, Z., Li, Q., Liu, T., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155758 · Cited by 22
Ming, Y., Zhao, P., Zhang, H., Zhang, Z., Huang, Z., Zhang, L., Sun, Y., & Li, X. (2024) · Inflammation · doi:10.1007/s10753-024-02155-7 · Cited by 18
“Activation of the microglial NLRP3 inflammasome can increase inflammation, stimulating neurotoxicity[56], triggering amyloid-beta oligomers, exacerbating Alzheimer[57], advancing the progression of dopaminergic neuropathology in Parkinson[58], and ultimately aggravating damage to brain and inflammation after recurrent…”
Specks of insight into Alzheimer’s disease
Ransohoff, R. M. (2017) · Nature · doi:10.1038/d41586-017-08668-6 · Cited by 20
Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
Fu, J., Wang, R., He, J., Liu, X., Wang, X., Yao, J., Liu, Y., Ran, C., Ye, Q., & He, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508023 · Cited by 25
“Some studies have shown that ASC specks released by microglia bind rapidly to amyloid-b and increase the formation of A b oligomers and aggregates, acting as an in fl ammation-driven cross-seed for A b pathology (107, 108).”
Zubillaga, M., Abadin, X., Ivars, E., Puigròs, M., Trullás, R., Bellini, M. J., Arnal, N., & Colell, A. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103872 · Cited by 19
“In AD, the release of microglia-derived ASC specks has been implicated in A β seeding [140] and proposed as a reliable fluid biomarker of inflammation [141].”
Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both?
Sharma, A., Parekh, B. K., Patil, V., Renuka Jyothi, S., Nayak, P. P., Janney, J. B., Singh, G., & Al-Hasnaawei, S. (2025) · Developmental Neurobiology · doi:10.1002/dneu.23015 · Cited by 20
“Inflammasome activity further contributes to this propagation, as microglia release ASC specks that bind A β , promoting oligomerization and aggregation (Venegas et al. 2017).”
A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer’s disease
Yang, Z., Liu, J., Wei, S., Deng, J., Feng, X., Liu, S., & Liu, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1077222 · Cited by 20
“In early AD patients, ASCbound Aβ is found in the brain, and levels of IL-1β and caspase-1 activity are significantly increased, supporting the above hypothesis (Venegas et al., 2017).”
BackgroundLi, T., Li, D., Wei, Q., Shi, M., Xiang, J., Gao, R., Chen, C., & Xu, Z. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106114 · Cited by 19
NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer’s Disease
Tao, S., Fan, W., Liu, J., Wang, T., Zheng, H., Qi, G., Chen, Y., Zhang, H., Guo, Z., & Zhou, F. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230567 · Cited by 18
Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets
Gu, X., Long, Q., Qi, Q., Zhou, J., Chen, S., & Wang, L. (2024) · BioScience Trends · doi:10.5582/bst.2023.01288 · Cited by 19
Kaur, S., Sharma, K., Sharma, A., Sandha, K. K., Ali, S. M., Ahmed, R., Ramajayan, P., Singh, P. P., Ahmed, Z., & Kumar, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1418422 · Cited by 18
“ASC specks secreted by immune cells directly bind to the A b and augment the accumulation of A b aggregates (11).”
NLRP3 Is Involved in the Maintenance of Cerebral Pericytes
Quan, W., Luo, Q., Tang, Q., Furihata, T., Li, D., Fassbender, K. C., & Liu, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00276 · Cited by 18
Selective inhibition of the K + efflux sensitive NLRP3 pathway by Cl − channel modulation
Swanton, T., Beswick, J. A., Hammadi, H., Morris, L. V., Williams, D. M., Cesco, S. D., El‐Sharkawy, L. Y., Yu, S., Green, J., Davis, J. B., et al. (2020) · Chemical Science · doi:10.1039/d0sc03828h · Cited by 17
Patten, K. T., Valenzuela, A. E., Wallis, C., Harvey, D. J., Bein, K. J., Wexler, A. S., Gorin, F. A., & Lein, P. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.861733 · Cited by 22
“In AD, inflammasome activation has been shown to seed Aβ plaques and contribute to Aβ plaque pathology (Heneka, 2017; Venegas et al., 2017; Tejera et al., 2019).”
BackgroundZhang, S., Liu, C., Sun, J., Li, Y., Lu, J. Y., Xiong, X., Hu, L., Zhao, H., & Zhou, H. (2023) · Aging and Disease · doi:10.14336/ad.2023.0501 · Cited by 18
“After the receptor or sensor hallmark activation and oligomerization, ASC assembles into a large protein complex called a "speck," a sign of inflammasome activation [127].”
Modulation of Innate Immunity by Amyloidogenic Peptides
Westwell-Roper, C. Y., & Verchere, C. B. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.005 · Cited by 18
Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice culture
Hoyle, C., Redondo‐Castro, E., Cook, J., Tzeng, T.-C. J., Allan, S. M., Brough, D., & Lemarchand, E. (2020) · Immunology · doi:10.1111/imm.13221 · Cited by 17
Emerging Roles of Microglia in Blood-Brain Barrier Integrity in Aging and Neurodegeneration
Zhang, S., Meng, R., Jiang, M., Qing, H., & Ni, J. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230203103910 · Cited by 16
Srinivasan, S., Kancheva, D., Ren, S. D., Saito, T., Jans, M., Boone, F., Vandendriessche, C., Paesmans, I., Maurin, H., Vandenbroucke, R. E., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1323409 · Cited by 18
Lei, Y., Chen, Y., Zhang, S., Wang, W. J., Zheng, M., & Zhang, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26923 · Cited by 16
“The activation of NLRP3 and A β deposition mutually exacerbate each other, resulting in the development of pathological characteristics resembling amyloid-like protein [11].”
BackgroundYun, Q., Ma, S.-F., Zhang, W., Gu, M., & Wang, J. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01467-4 · Cited by 18
“Furthermore, the NLRP3 inflammasome activation in microglia can enhance the formation of the Aβ-ASC complex by facilitating the binding of the adapter protein ASC with Aβ (Venegas et al. 2017).”
BackgroundTherapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease
Serradas, M. L., Ding, Y., Martorell, P., Kulińska, I., & Castro‐Gomez, S. (2024) · Cells · doi:10.3390/cells13171426 · Cited by 17
“Furthermore, Ising et al. showed reduced levels of p-tau in Nlrp3 − / − crossed with the Tau22 mouse model [168,170].”
BackgroundInfluentialPhysiological roles of embryonic microglia and their perturbation by maternal inflammation
Shimamura, T., Kitashiba, M., Nishizawa, K., & Hattori, Y. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1552241 · Cited by 16
Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease
Okafor, M., Faller, P., & Vitale, N. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00504-6 · Cited by 18
“ASC favours seeding of Aβ, as ASC specks are found in the core of plaques and accelerate oligomer formation and possibly the spreading of amyloid pathology [283].”
Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
Klimmt, J., Dannert, A., & Paquet, D. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.008 · Cited by 16
Wang, X., Liu, E.-J., Liu, Q. R., Li, S., Li, T., Zhou, Q., Liu, Y., Zhang, H., & Wang, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200529 · Cited by 16
“Microglia maytakeuptauaggregatesthroughendocytosisand exhalation[14–16],whichgenerallycausesfurther accumulationoftau[17].”
Childers, G. M., Perry, C. A., Blachut, B., Martin, N. P., Bortner, C. D., Sieber, S. O., Li, J., Fessler, M. B., & Harry, G. J. (2021) · Environmental Health Perspectives · doi:10.1289/ehp8314 · Cited by 16
“…et al. 2017; Cypryk et al. 2018) and oligomeric NLRP3 inflammasome particles (BarojaMazo et al. 2014; Franklin et al. 2014) are factors that act upon adjacent cells to activate the NF-jB signal pathway, alter lysosome integrity, and enhance or prolong the immune response (Venegas et al. 2017).”
BackgroundThe Role of Immunity in Alzheimer's Disease
McManus, R. M. (2022) · Advanced Biology · doi:10.1002/adbi.202101166 · Cited by 18
Andras, I. E., García-Contreras, M., Yanick, C., Perez, P., Sewell, B., Durand, L., & Toborek, M. J. (2020) · Molecular Brain · doi:10.1186/s13041-020-0562-0 · Cited by 16
Sabbagh, M. N., Cummings, J. L., Ballard, C. G., van der Flier, W. M., Heneka, M. T., Holst, J. J., Knudsen, L. B., Salloway, S., Tansey, M. G., & Drucker, D. J. (2025) · Nature Aging · doi:10.1038/s43587-025-01029-3 · Cited by 17
“This leads to the seeding of Aβ deposition 15 , release of interleukin-1β (IL-1β) and subsequent tau phosphorylation 16 .”
Self-citationCyr, B. S., Ranaldi, E. D. L. R. M. C., Hadad, R., Dietrich, W. D., Keane, R. W., & Vaccari, J. P. D. R. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1369781 · Cited by 15
“ASC specks cross-link with A β , suggesting a role in AD (Venegas et al., 2017).”
BackgroundShahbaz, S. K., Koushki, K., Hedayati, S. K., McCloskey, A. P., Kesharwani, P., Naderi, Y., & Sahebkar, A. (2024) · Medicinal Research Reviews · doi:10.1002/med.22064 · Cited by 15
“26 This occurs 1 h after cerebral ischemia, and 24 – 48 h later, activated microglia are seen throughout the ischemic region.”
The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis
Losa, M., Emmenegger, M., Rossi, P. D., Schürch, P. M., Serdiuk, T., Pengo, N., Capron, D., Bieli, D., Bargenda, N., Rupp, N. J., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00107-0 · Cited by 15
“This fi nding re fl ects the literature as the ASC pyrin domain, besides its well-known ASC-homodimerization characteristics (Fernandes-Alnemri et al, 2007; Oroz et al, 2016; Vajjhala et al, 2012), is described to be a protein interaction domain (de Alba, 2019; Venegas et al, 2017).”
InfluentialYassaghi, Y., Nazerian, Y., Ghasemi, M., Nazerian, A., Sayehmiri, F., Perry, G. L., & Pourbadie, H. G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18554 · Cited by 15
“101,102 Seed-induced A β deposits are involved in neurogenesis impairments and cell death induction, leading to cognitive decline and memory impairment.”
BackgroundMicroglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
Hussain, M. S., Khan, Y., Fatima, R., Maqbool, M., Ramalingam, P. S., Khan, M. G., & Bisht, A. S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050364292250113063513 · Cited by 18
Autophagy and Immune-Related Diseases
Tan, P., Ye, Y., Mao, J., & He, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-0606-2_10 · Cited by 15
Chen, Q., Tu, Y., Mak, S., Chen, J., Lu, J., Chen, C., Yang, X., Wang, S., Wen, S., Ma, S., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173361 · Cited by 15
Yu, X., Yu, C., & He, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.952211 · Cited by 17
“This research team further revealed that NLRP3 inflammasome activation was related to ASC-speck cross-seeding of Aβ pathology in AD mice models, suggesting the essential role of NLRP3 inflammasome in the genesis and development of Aβ pathology (Venegas et al., 2017).”
BackgroundC4b-binding protein inhibits particulate- and crystalline-induced NLRP3 inflammasome activation
Bierschenk, D., Papac-Miličević, N., Bresch, I. P., Kovacic, V., Bettoni, S., Dziedzic, M., Wetsel, R. A., Eschenburg, S., Binder, C. J., Blom, A. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149822 · Cited by 15
“ASC polymerisation has many similarities to amyloid fibrillation, and ASC specks can even cross-seed amyloid formation (32).”
BackgroundSystemic immunosuppression and risk of age-related macular degeneration
Sandhu, H. S., Lambert, J., Xu, Y., & Kaplan, H. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203492 · Cited by 15
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 17
“94 showed ASC specks could accelerate the deposition of A β ; the activation of the innate immune system in Alzheimer’s disease involves the inflammasome-dependent formation of ASC specks in microglia.”
InfluentialDongre, P., Ramesh, M., Govindaraju, T., & Inamdar, M. S. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03415-5 · Cited by 14
“Abrogating neuroinflammation by deletion of Nlrp3 or ASC does not affect plaque load at early stages of disease (4–5 months) but reduces plaque load at later stages (8–16 months) [56–58].”
Wood, J. I., Dulewicz, M., Szadziewska, A., Weiner, S., Ge, J., Stringer, K. M., Desai, S., Fenson, L., Piotrowska, D., Brinkmalm, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63328-y · Cited by 14
Romero‐Molina, C., Navarro, V., Jiménez, S., Muñoz‐Castro, C., Sanchez-Mico, M. V., Gutiérrez, A., Vitórica, J., & Vizuete, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189734 · Cited by 16
Wang, J., Zhu, X., Li, Y., Zhang, P., Wang, T., & Li, M. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6091671 · Cited by 15
“During this process, ASC can bind to Aβ to further induce the production of Aβ oligomers [58], and inflammasomes can weaken the phagocytic function of microglia to take up Aβ, disrupting Aβ clearance [59].”
BackgroundLiu, W., Chen, S., Rao, X., Yang, Y., Chen, X., & Yu, L. (2023) · Biomedicines · doi:10.3390/biomedicines11010194 · Cited by 17
“These ASC specks are inflammation-driven and bind rapidly to amyloid beta, contributing to increased formation of amyloid-beta oligomers and aggregates that are responsible for the deposition of the pathological amyloid-beta plaques [47,48].”
BackgroundMuto, E., Okada, T., Yamanaka, T., Uchino, H., & Inazu, M. (2023) · Biomolecules · doi:10.3390/biom13020191 · Cited by 15
Hermann, D. M., Bacigaluppi, M., Bassetti, C. L., Bassotti, G., Boltze, J., Chan, A., Dalkara, T., Denes, A., Diez-Tejedor, E., Dodel, R., et al. (2025) · Exploration of Neuroscience · doi:10.37349/en.2025.1006106 · Cited by 13
The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target
Liu, G., Zhang, L., Fan, Y., & Ji, W. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206150 · Cited by 14
“Human and in vivo studies have revealed that the NLRP3 inflammasome is triggered in AD and ASC specks are indicated in the amyloid plaque core [144].”
BackgroundDoroszkiewicz, J., Kulczyńska‐Przybik, A., Dulewicz, M., Mroczko, J., Borawska, R., Słowik, A., Zetterberg, H., Hanrieder, J., Blennow, K., & Mroczko, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147543 · Cited by 14
“By continuously releasing pro-inflammatory cytokines, chronically activated microglia and astrocytes can cause brain injury by making neurons more susceptible to cell death and encouraging the creation of dangerous protein aggregates [6,12,13].”
BackgroundComparison of Methods of Detecting IL-1β in the Blood of Alzheimer’s Disease Subjects
Remnitz, A. D., Hadad, R., Keane, R. W., Dietrich, W. D., & Vaccari, J. P. D. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020831 · Cited by 14
“Importantly, A β plaques form in part when A β monomers bind to ASC specks [40].”
Bone marrow B lymphopoiesis accelerates early cerebral amyloid pathology
Zhang, J., Fang, W., Liu, H., Li, R., Zhu, Z., Wu, X., Yao, S., Fu, Y., Li, R. Q., Chen, W., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02419-0 · Cited by 18
Mitophagy in Alzheimer's disease and its potential as a therapeutic target
Wei, J., Xiao, T., Lyu, J., Zhao, Y., Zhang, Y., Du, X., He, Y., Zhao, M., Yang, X., Yao, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107162 · Cited by 15
Liver Growth Factor “LGF” as a Therapeutic Agent for Alzheimer’s Disease
Gonzalo‐Gobernado, R., Perucho, J., Vallejo-Muñoz, M., Casarejos, M. J., Reimers, D., Jiménez‐Escrig, A., Gómez, A., de Asanza, G. M. U., & Bazán, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239201 · Cited by 13
“Because ASC released by microglia forms an aggregate complex with Aβ that promotes inflammation [37,39], we may argue that ASC reduction is associated with a potential anti-inflammatory effect of LGF in this experimental model of AD.”
BackgroundThe inflammasome in biomaterial‐driven immunomodulation
Vasconcelos, D. P., Águas, A. P., & Barbosa, J. N. (2022) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3361 · Cited by 14
Advances in proteomic phenotyping of microglia in neurodegeneration
Sunna, S. N., Bowen, C. A., Ramelow, C. C., Santiago, J. V., Kumar, P., & Rangaraju, S. (2023) · PROTEOMICS · doi:10.1002/pmic.202200183 · Cited by 13
Metadata
- Authors
- Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., Griep, A., Gelpi, E., Beilharz, M., Riedel, D., Golenbock, D. T., Geyer, M., Walter, J., Latz, E., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 355-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777928756
- Semantic Scholar
- cb17ef0ab08a09442fa73b451fad4635f8d4ab3b
- Cited by
- 983
- References
- 33
- Citations by year
- 2026: 90 · 2025: 112 · 2024: 135 · 2023: 129 · 2022: 130 · 2021: 129 · 2020: 108 · 2019: 81 · 2018: 64 · 2017: 1
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, ASC specks, microglia, inflammasome, cross-seeding, amyloid-beta oligomers, innate immunity, neuroinflammation, amyloid-beta aggregation
- MeSH terms
- Protein Domains, Alzheimer Disease, Animals, Antibodies, Female, Hippocampus, Humans, Inflammation, Mice, Inbred C57BL, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Knockout, Mice, CARD Signaling Adaptor Proteins, Presenilin-1, Inflammasomes, Spatial Memory, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.